Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report

  • Anjila Koul
  • Niklas Loman
  • Susanne Malander
  • Åke Borg
  • Mona Ridderheim
Publishing year: 2001
Language: English
Pages: 399-402
Publication/Series: Gynecologic Oncology
Volume: 80
Issue: 3
Document type: Journal article
Publisher: Academic Press

Abstract english

BACKGROUND: Cerebral metastasis secondary to ovarian cancer is a rare phenomenon. While no clear relationship to known prognostic factors is found, others suggest this as a biologically diverse behavior of ovarian cancer. CASES: In a pilot study, 37 invasive epithelial ovarian cancer samples were analyzed to detect the frequency of BRCA1/BRCA2 mutations in the south of Sweden (results published). A retrospective follow-up revealed that 2 of these (2/37; 5.4%) patients developed central nervous system metastases during the course of their disease. Both patients had advanced surgical stage disease at the time of diagnosis, with histopathological serous type tumors that were negative for estrogen and progesterone receptors. One of these patients carried a germline BRCA1 mutation, whereas a somatic BRCA1 mutation was identified in the other patient. CONCLUSIONS: To the best of our knowledge the molecular genetic profile of these tumors is not found in the literature and it is suggested that such analyses could provide some insight for a better understanding of this rare phenomenon.


  • Cancer and Oncology
  • BRCA1 mutation
  • ovarian tumor
  • CNS


  • ISSN: 1095-6859
Åke Borg
Åke Borg
E-mail: ake [dot] borg [at] med [dot] lu [dot] se

Principal investigator

Oncology and Pathology, MV

+46 46 275 25 52

MV 404 C21B2


Project manager

Familial Breast Cancer



Oncology and Pathology, MV

MV 404 C21C2